Argonaut Therapeutics Overview
- Year Founded
-
2016
- Status
-
Acquired/Merged
- Employees
-
9
- Latest Deal Type
-
M&A
- Investors
-
1
Argonaut Therapeutics General Information
Description
Developer of novel epigenetic therapies designed to offer treatment for arginine methylation in cancer. The company offers cancer drugs that reprogram cancer cells to undergo the body's natural process of cell death, enabling patients to get advanced treatment and recover faster.
Contact Information
Website
www.argonauttherapeutics.co.ukCorporate Office
- The Magdalen Centre, Oxford Science Park
- Robert Robinson Avenue
- Oxford OX4 4GA
- England, United Kingdom
Corporate Office
- The Magdalen Centre, Oxford Science Park
- Robert Robinson Avenue
- Oxford OX4 4GA
- England, United Kingdom
Argonaut Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 05-Jan-2023 | Completed | Clinical Trials - Phase 1 | |||
| 4. Early Stage VC (Series B) | 19-Sep-2018 | Completed | Pre-Clinical Trials | |||
| 3. Early Stage VC (Series A) | 21-Dec-2017 | Completed | Pre-Clinical Trials | |||
| 2. Seed Round | 19-Oct-2016 | $635K | $635K | Completed | Pre-Clinical Trials | |
| 1. University Spin-Out | 01-Jan-2016 | Completed | Startup |
Argonaut Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 4,630 | $0.129680 | $140.05 | $140.05 | 1x | $140.05 | 10.28% | |
| Ordinary | 6,667 | $0.129680 | $97.25 | $97.25 | 1x | $97.25 | 14.81% |
Argonaut Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Argonaut Therapeutics Patents
Argonaut Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202203588-D0 | Cancer diagnostic | Inactive | 15-Mar-2022 | ||
| AU-2023236994-A1 | Cancer diagnostics and treatment by means of prmt5 inhibitor | Pending | 15-Mar-2022 | ||
| EP-4493726-A1 | Cancer diagnostics and treatment by means of prmt5 inhibitor | Pending | 15-Mar-2022 | ||
| GB-202117230-D0 | Peptide vaccine | Inactive | 29-Nov-2021 | ||
| CA-3239043-A1 | Peptide vaccine | Pending | 29-Nov-2021 | A61K39/0011 |
Argonaut Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Argonaut Therapeutics Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| JW Pharmaceutical | Corporation | Minority | ||
| Oxford Science Enterprises | Venture Capital | Minority | ||
| Oxford Spin-out Equity Management | Venture Capital | Minority |
Argonaut Therapeutics FAQs
-
When was Argonaut Therapeutics founded?
Argonaut Therapeutics was founded in 2016.
-
Where is Argonaut Therapeutics headquartered?
Argonaut Therapeutics is headquartered in Oxford, United Kingdom.
-
What is the size of Argonaut Therapeutics?
Argonaut Therapeutics has 9 total employees.
-
What industry is Argonaut Therapeutics in?
Argonaut Therapeutics’s primary industry is Drug Discovery.
-
Is Argonaut Therapeutics a private or public company?
Argonaut Therapeutics is a Private company.
-
What is Argonaut Therapeutics’s current revenue?
The current revenue for Argonaut Therapeutics is .
-
How much funding has Argonaut Therapeutics raised over time?
Argonaut Therapeutics has raised $6.83M.
-
Who are Argonaut Therapeutics’s investors?
JW Pharmaceutical, Oxford Science Enterprises, and Oxford Spin-out Equity Management have invested in Argonaut Therapeutics.
-
When was Argonaut Therapeutics acquired?
Argonaut Therapeutics was acquired on 05-Jan-2023.
-
Who acquired Argonaut Therapeutics?
Argonaut Therapeutics was acquired by IngenOx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
